Scopus Asset Management’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Hold |
0
| – | – | – | 275 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 225 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 183 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 148 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 138 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 151 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 167 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 148 |
|
|
2018
Q4 | – | Sell |
-11
| Closed | -$7K | – | 149 |
|
|
2018
Q3 | $7K | Hold |
11
| – | – | ﹤0.01% | 145 |
|
|
2018
Q2 | $24K | Hold |
11
| – | – | ﹤0.01% | 157 |
|
|
2018
Q1 | $32K | Hold |
11
| – | – | ﹤0.01% | 173 |
|
|
2017
Q4 | $51K | Hold |
11
| – | – | ﹤0.01% | 189 |
|
|
2017
Q3 | $93K | Hold |
11
| – | – | ﹤0.01% | 177 |
|
|
2017
Q2 | $57K | Hold |
11
| – | – | ﹤0.01% | 174 |
|
|
2017
Q1 | $63K | Hold |
11
| – | – | ﹤0.01% | 165 |
|
|
2016
Q4 | $76K | Buy |
+11
| New | +$76K | ﹤0.01% | 153 |
|